Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries

References

• Moore S. Labelling and its role in pharmaceutical packaging. International Pharmaceutical Industry. 2012;4(3):114–8.
   Google Scholar
• Guchelaar HJ, Kalmeijer MD, Jansen ME. Medication error due to ambiguous labelling of a commercial product. Pharm World Sci. 2004;26(1):10.
   PubMedGoogle Scholar
• Hellier E, Edworthy J, Derbyshire N, Costello A. Considering the impact of medicine label design characteristics on patient safety. Ergonomics. 2006;49(5–6):617–30.
   PubMed Web of Science ®Google Scholar
• Veronin M. Packaging and labeling of pharmaceutical products obtained from the internet. J Med Internet Res. 2011;13(1):e22.
   PubMed Web of Science ®Google Scholar
• Nonyelum SC, Nkem N, Ifeyinwa CN, Orisakwe OE. Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement? J Pak Med Assoc. 2010;60(10):801–4.
   PubMed Web of Science ®Google Scholar
• Athuraliya N, Walkom EJ, Dharmaratne S, Robertson J. Assessing medication packaging and labelling appropriateness in Sri Lanka. J Pharmaceutical Policy Pract. 2016;9:38.
   PubMedGoogle Scholar
• Neoh CF, Hassali MA, Shafie AA, Awaisu A, Tambyappa J. Compliance towards dispensed medication labelling standards: a sross-sectional study in the state of Penang, Malaysia. Curr Drug Saf. 2009;4(3):199–203.
   PubMedGoogle Scholar
• Poudel A, Mohamed Ibrahim MI, Mishra P, Palaian S. Assessment of the availability and rationality of unregistered fixed dose drug combinations in Nepal: a multicenter cross sectional study. Glob Health Res Policy. 2017;2:14.
   PubMedGoogle Scholar
• Poudel BK, Ishii I, Khakurel B. Assessment of regulatory compliance in selected pharmacy outlets of Nepal. J Pharm Health Serv Res. 2016;7(1):31–6.
   Google Scholar
• Gyanwali P, Humagain BR, Aryal KK, Pandit A, Acharya T, Bista B, et al. Surveillance of quality of medicines available in the Nepalese market: A study from Kathmandu Valley. J Nepal Health Res Counc. 2015;13(31):233–40.
   PubMedGoogle Scholar
• Department of Drug Administration. Drugs Standard regulation, 2043(1986). http://www.dda.gov.np/content/drug-standard-regulation-2043. Assessed 12 Nov 2017.
   Google Scholar
• Maciejewski CS. The dilemma over foreign-language labeling of over-the-counter drugs. J Leg Med. 1994;15(1):129–54.
   PubMed Web of Science ®Google Scholar
• Department of Drug Administration. Notice (151/073/74) (Nepali). Department of Drug Administration, Kathmandu, Nepal.
   Google Scholar
• Khadka DB. News related to misclassification of drug by Nepalese Pharmaceutical industries (Nepali). http://swasthyakhabar.com/news-details/1321/2016-10-27. Assessed 12 Nov 2017.
   Google Scholar
• World Health Organization, Regional Office for South East Asia. Medicines in health care delivery Nepal: Situational analysi. 2014. http://www.searo.who.int/entity/medicines/nepal2014.pdf. Assessed 10 Dec 2017.
   Google Scholar
• Orser B. Reducing medication errors. CMAJ. 2000;162(2):1150–1.
   PubMedGoogle Scholar
• Brass EP, Weintraub M. Label development and the label comprehension study for over the counter drugs. Clin Pharmacol Ther. 2003;74(5):406–12.
   PubMed Web of Science ®Google Scholar
• Peterson GM, Wu MS, Beggin JK. Pharmacists’ attitudes towards dispensing errors, their causes and prevention. J Clin Pharm Ther. 1999;24(1):57–71.
   PubMed Web of Science ®Google Scholar
• Wieniawski W. Role and functions of the international pharmacopoeia. Ann Ist Super Sanita. 1975;11(3–4):204–10.
   PubMedGoogle Scholar
• Braun CC. Silver NC. Interaction of signal words and color on warning labels: differences in perceived hazard and behavioral compliance. Ergonomics 1995;38. 11:2207–20.
   Google Scholar
• Wogalter MS, Jarrard SW, Simpson SN. Influence of warning label signal words on perceived hazard level. Hum Factors. 1994;36(3):547–56.
   PubMed Web of Science ®Google Scholar
• Aronson JK. Medication errors: what they are, how they happen, and how to avoid them. QJM. 2009;102(8):513–21.
   PubMed Web of Science ®Google Scholar
• Leyva M, Sharif I, Ozuah PO. Health literacy among Spanish-speaking Latino parents with limited English proficiency. Ambul Pediatr. 2005;5(1):56–9.
   PubMedGoogle Scholar
• Bradshaw M, Tomany-Korman S, Flores G. Language barriers to prescriptions for patients with limited English proficiency: a survey of pharmacies. Pediatrics. 2007;120(2):e225–35.
   PubMed Web of Science ®Google Scholar
• Weiss L, Gany F, Rosenfeld P, Carrasquillo O, Sharif I, Behar E, et al. Access to multilingual medication instructions at new York City pharmacies. J Urban Health. 2007;84(6):742–54.
   PubMed Web of Science ®Google Scholar
• Sharif I, Lo S, Ozuah PO. Availability of Spanish prescription labels. J Health Care Poor Underserved. 2006;17(1):65–9.
   PubMed Web of Science ®Google Scholar
• Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optom Assoc. 1994;65(1):32–7.
   PubMedGoogle Scholar
• Wogalter MS, Vigilante WJJr. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergonomics. 2003;46(4):327–44.
   PubMed Web of Science ®Google Scholar
• Filik R, Purdy K, Gale A, Gerrett D. Drug name confusion: evaluating the effectiveness of capital (tall man) letters using eye movement data. Soc Sci Med. 2004;59:2597–601.
   PubMed Web of Science ®Google Scholar